Oct 12, 2023 - School of Medicine research contributed to first pill approved for postpartum depression
Dr. Reddy’s neurosteroid replacement therapy research laid the groundwork for zuranolone (Zurzuvae), approved by the FDA in 2023 as the first oral pill for postpartum depression. Featured in Vital Record. Read the article